Unlock stock picks and a broker-level newsfeed that powers Wall Street.
11.73
-0.42
(-3.46%)
As of 10:18:17 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 14 | 11 |
| Avg. Estimate | -0.77 | -0.78 | -3.15 | -3.21 |
| Low Estimate | -0.89 | -0.94 | -3.82 | -4.78 |
| High Estimate | -0.58 | -0.55 | -2.42 | -1.62 |
| Year Ago EPS | -0.76 | -0.71 | -2.88 | -3.15 |
Revenue Estimate
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 17 | 15 |
| Avg. Estimate | 12.32M | 13.12M | 54.36M | 63.73M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 18M | 22.65M | 80M | 209.4M |
| Year Ago Sales | 16.59M | 12.09M | 54.55M | 54.36M |
| Sales Growth (year/est) | -25.73% | 8.53% | -0.34% | 17.24% |
Earnings History
| Currency in USD | 2/29/2024 | 5/31/2024 | 8/31/2024 | 11/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.79 | -0.63 | -0.68 | -0.67 |
| EPS Actual | -0.76 | -0.71 | -0.67 | -0.75 |
| Difference | 0.03 | -0.08 | 0.01 | -0.08 |
| Surprise % | 3.90% | -11.86% | 1.84% | -12.13% |
EPS Trend
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.77 | -0.78 | -3.15 | -3.21 |
| 7 Days Ago | -0.76 | -0.77 | -3.1 | -3.2 |
| 30 Days Ago | -0.75 | -0.76 | -3.09 | -3.13 |
| 60 Days Ago | -0.68 | -0.7 | -2.76 | -2.93 |
| 90 Days Ago | -0.67 | -0.67 | -2.76 | -2.98 |
EPS Revisions
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 3 |
| Up Last 30 Days | -- | -- | 1 | 3 |
| Down Last 7 Days | 7 | 8 | 12 | 6 |
| Down Last 30 Days | 6 | 7 | 12 | 6 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NRIX | -1.39% | -10.43% | -9.47% | -1.75% |
| S&P 500 | 16.20% | 6.69% | 10.00% | 14.33% |
Upgrades & Downgrades
| Initiated | Leerink Partners: Market Perform | 3/17/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 2/3/2025 |
| Maintains | RBC Capital: Outperform to Outperform | 1/29/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 1/29/2025 |
| Maintains | Stifel: Buy to Buy | 1/29/2025 |
| Maintains | Needham: Buy to Buy | 1/29/2025 |
Related Tickers
KYMR Kymera Therapeutics, Inc.
27.93
-5.71%
ORIC ORIC Pharmaceuticals, Inc.
5.68
-7.52%
ACLX Arcellx, Inc.
63.47
-6.61%
FHTX Foghorn Therapeutics Inc.
3.4800
-1.14%
RVMD Revolution Medicines, Inc.
34.99
-6.32%
ITOS iTeos Therapeutics, Inc.
5.87
-7.12%
COGT Cogent Biosciences, Inc.
6.02
-7.10%
VRDN Viridian Therapeutics, Inc.
13.61
-5.74%
BCYC Bicycle Therapeutics plc
8.58
-4.35%
NUVL Nuvalent, Inc.
69.40
-5.00%